Market and Trading Information for Denali Therapeutics
The following details were available for trading and market data about the stock of Denali Therapeutics as of writing:
Trading Details of Denali Therapeutics (DNLI)
Current Share Price:
$17.84
Previous Year's Closing Price:
$21.46
Percentage Price Change (YTD):
-16.87%
Market Cap:
$2.54 billion
52-week Price Range:
$15.45 - $33.31
Dividend Per Share:
$0
EPS (TTM):
-1.06
Price-Earnings (Trailing):
0
Price-Earnings (Forward):
-6.89
Company Profile and Business Description for Denali Therapeutics
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidates, including DNL201 and DNL151, which are in Phase 1 clinical t...to see full details, pleaseLogin / Register to view.
ETFs Holding Denali Therapeutics Stock
As of March 2020, the following exchange-traded funds (ETF) hold the Denali Therapeutics stocks in their respective portfolios. Below is a random list of only 10 ETFs in no particular order that have Denali Therapeutics stock holding. There are a total of 28 ETFs in Fknol.com records which are holding Denali Therapeutics stock in their portfolio. See Full List.
The Virtus LifeSci Biotech Clinical Trials ETF tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. ...Full Details
The Vanguard ESG U.S. Stock ETF tracks a market-cap-weighted index of US companies screened for environmental, social, and corporate governance (ESG) criteria. ...Full Details
The iShares MSCI USA Small-Cap ESG Optimized ETF tracks an index of small-cap companies with high environmental, social, and governance (ESG) factor scores as determined by MSCI. ...Full Details
The First Trust Multi Cap Growth Opportunities AlphaDex ETF tracks an index that uses fundamental factors to select and weight growth stocks from the S&P 1500 Growth Index. ...Full Details
The First Trust Small Cap Growth AlphaDex ETF tracks a quant-driven index that select stocks from a small-cap growth universe in an attempt to outperform the market. ...Full Details
The First Trust Small Cap Core AlphaDex ETF tracks an index of small-cap stocks selected from the S&P 600 Index based on quantitatively driven growth and value factors. ...Full Details
The iShares NASDAQ Biotechnology ETF tracks the performance of a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. ...Full Details ...Candlestick Patterns.
The iShares Core S&P Total U.S. Stock Market ETF tracks a market cap-weighted index of all common equities listed on the NYSE and the NASDAQ. ...Full Details
See Full List of ETFs holding Denali Therapeutics stock in their respective portfolios.
U.S. Stock Screener:
Peer / Competitor Companies of Healthcare Sector
Along with Denali Therapeutics Inc., the following other peer (competitor) companies also exist within the same Healthcare - Healthcare sector whose company profile and dividend history is as follows:
▶ Acer Therapeutics (ACER): Acer Therapeutics Inc., a pharmaceutical company, develops therapies for the treatment of rare diseases with critical unmet medical needs. Its product candidates include Celiprolol for the treatment of vascular....See Detailed Company Profile, Dividend History
▶ Achieve Life Sciences (ACHV): Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers Cytisine, a plant-based alka....See Detailed Company Profile, Dividend History
▶ Adial Pharmaceuticals (ADIL): Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic agents for the treatment of alcohol use disorders in the United States. Its lead product is AD0....See Detailed Company Profile, Dividend History
▶ Aerpio Pharmaceuticals (ARPO): Aerpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for ocular diseases. The company's lead product candidate is AKB-9778, a small molecule activator ....See Detailed Company Profile, Dividend History
▶ AgeX Therapeutics (AGE): AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of therapeutics for age-related degenerative diseases in the United Stated. The company is developing AGEX-BAT1....See Detailed Company Profile, Dividend History
▶ Aileron Therapeutics (ALRN): Aileron Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing a novel class of therapeutics in the United States. The company's lead product candidate is ALRN....See Detailed Company Profile, Dividend History
▶ Akcea Therapeutics (AKCA): Akcea Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing drugs to treat patients with cardiometabolic diseases caused by lipid disorders in the United States a....See Detailed Company Profile, Dividend History
▶ Allakos (ALLK): Allakos Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutic antibodies targeting allergic, inflammatory, and proliferative diseases. The company is developing AK002 for the treat....See Detailed Company Profile, Dividend History
▶ Allena Pharmaceuticals (ALNA): Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in the development and commercialization of oral enzyme therapeutics to treat patients with rare and severe metabolic, and ....See Detailed Company Profile, Dividend History
▶ Allogene Therapeutics (ALLO): Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, engages in the research, development, and commercialization of genetically engineered allogeneic T cell therapies for the treatment of canc....See Detailed Company Profile, Dividend History
▶ Alpine Immune Sciences (ALPN): Alpine Immune Sciences, Inc. focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, inflammatory disorders, and other diseases. Its lead programs include ALPN-101....See Detailed Company Profile, Dividend History
▶ Altimmune (ALT): Altimmune, Inc., a clinical stage immunotherapeutic biotechnology company, focuses on discovering and developing immunotherapies and vaccines to address the unmet medical needs. The company develops NasoVAX, an....See Detailed Company Profile, Dividend History
▶ Amneal Pharmaceuticals (AMRX): Amneal Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and distributes generic pharmaceutical products for various dosage forms and therapeutic areas. It operates thr....See Detailed Company Profile, Dividend History
▶ AN2 Therapeutics (ANTX): AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, ....See Detailed Company Profile, Dividend History
▶ AnaptysBio (ANAB): AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing antibody product candidates focused on unmet medical needs in inflammation. The company's proprietary anti-inflammatory pipeline i....See Detailed Company Profile, Dividend History
▶ Anixa Biosciences (ANIX): Anixa Biosciences, Inc., a cancer-focused biotechnology company, develops both diagnostics and therapeutics to detect cancer. The company is developing the Cchek platform, a series of non-invasive blood tests f....See Detailed Company Profile, Dividend History
▶ Apellis Pharmaceuticals (APLS): Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutic compounds for autoimmune and inflammatory diseases. Its lead product candidate is APL-2....See Detailed Company Profile, Dividend History
▶ Aphria (APHA): Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health p....See Detailed Company Profile, Dividend History
▶ Aptinyx (APTX): Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous....See Detailed Company Profile, Dividend History
▶ Aptorum Group (APM): Aptorum Group Limited, a pharmaceutical company, develops and commercializes a range of therapeutic and diagnostic technologies to treat unmet medical needs. It focuses on developing various drug molecules and ....See Detailed Company Profile, Dividend History